Literature DB >> 34472889

I feel good? Anhedonia might not mean "without pleasure" for people treated for opioid use disorder.

Samuel W Stull1, Jeremiah W Bertz1, Leigh V Panlilio1, William J Kowalczyk1, Karran A Phillips1, Landhing M Moran1, Jia-Ling Lin1, Massoud Vahabzadeh1, Patrick H Finan2, Kenzie L Preston1, David H Epstein1.   

Abstract

Anhedonia is usually defined as partial or total loss of the capacity for pleasure. People with anhedonia in the context of major depressive disorder may have an unexpected capacity for event-related mood brightening, observable when mood is assessed dynamically (with smartphone-based ecological momentary assessment [EMA]) rather than only statically via questionnaire. We used EMA to monitor mood and pleasant events for 4 weeks in 54 people being treated with opioid agonist medication for opioid-use disorder (OUD), which is also associated with anhedonia, said to manifest especially as loss of pleasure from nondrug reward. We compared OUD patients' EMA reports with those of 47 demographically similar controls. Background positive mood was lower in OUD patients than in controls, as we hypothesized (Cohen ds = .85 to 1.32, 95% CIs [.66, 1.55]), although, contrary to our hypothesis, background negative mood was also lower (ds = .82 to .85, 95% CIs [.73, .94]). As hypothesized, instances of nondrug pleasure were as frequent in OUD patients as in controls-and were not rated much less pleasurable (d = .18, 95% CI [-.03, .35]). Event-related mood brightening occurred in both abstinent and nonabstinent OUD patients (ds = .18 to .37, CIs [-.01, .57]) and controls (ds = .04 to .60, CIs [-.17, .79]), brightening before each event began earlier for controls than OUD patients, but faded similarly postevent across groups. Our findings add to the evidence that anhedonia does not rule out reactive mood brightening, which, for people with OUD being treated on opioid agonist medication, can be elicited by nondrug activities. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Entities:  

Mesh:

Year:  2021        PMID: 34472889      PMCID: PMC8425598          DOI: 10.1037/abn0000674

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  52 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

Review 2.  The Brain on Drugs: From Reward to Addiction.

Authors:  Nora D Volkow; Marisela Morales
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

3.  Anhedonia in the age of RDoC.

Authors:  Jeffrey S Bedwell; Diane Carol Gooding; Chi C Chan; Benjamin J Trachik
Journal:  Schizophr Res       Date:  2014-11-10       Impact factor: 4.939

4.  Intact responses to non-drug rewards in long-term opioid maintenance treatment.

Authors:  Marie Eikemo; Philipp P Lobmaier; Mads L Pedersen; Nikolaj Kunøe; Anna Maria Matziorinis; Siri Leknes; Monica Sarfi
Journal:  Neuropsychopharmacology       Date:  2019-03-31       Impact factor: 7.853

5.  Neural reward response to substance-free activity images in opiate use disorder patients with depressive symptoms.

Authors:  Jennifer Y Yi; Gabriel S Dichter; Elizabeth D Reese; Ryan P Bell; Anna D Bartuska; Jennifer R Stein; Stacey B Daughters
Journal:  Drug Alcohol Depend       Date:  2019-03-20       Impact factor: 4.492

6.  Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls.

Authors:  Susana Da Silva; Sarah Saperia; Ishraq Siddiqui; Gagan Fervaha; Ofer Agid; Z Jeff Daskalakis; Arun Ravindran; Aristotle N Voineskos; Konstantine K Zakzanis; Gary Remington; George Foussias
Journal:  Psychiatry Res       Date:  2017-04-23       Impact factor: 3.222

7.  Summary of the DSM-IV mood disorders field trial and issue overview.

Authors:  M B Keller; D L Hanks; D N Klein
Journal:  Psychiatr Clin North Am       Date:  1996-03

8.  Results of the DSM-IV mood disorders field trial.

Authors:  M B Keller; D N Klein; R M Hirschfeld; J H Kocsis; J P McCullough; I Miller; M B First; C P Holzer; G I Keitner; D B Marin
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

9.  Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

Authors:  F H Gawin; H D Kleber
Journal:  Arch Gen Psychiatry       Date:  1986-02

10.  The dynamical signature of anhedonia in major depressive disorder: positive emotion dynamics, reactivity, and recovery.

Authors:  Vera E Heininga; Egon Dejonckheere; Marlies Houben; Jasmien Obbels; Pascal Sienaert; Bart Leroy; Joris van Roy; Peter Kuppens
Journal:  BMC Psychiatry       Date:  2019-02-08       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.